Ugrás a tartalomhoz

mirtazapine

A Wikiszótárból, a nyitott szótárból
(Mirtazapin szócikkből átirányítva)
mirtazapine
Clinical data
Trade namesRemeron, others
Other namesMepirzapine; 6-Azamianserin; ORG-3770
AHFS/Drugs.comMonograph
MedlinePlusa697009
License data
Pregnancy
category
  • AU: B3
Routes of
administration
By mouth, topical
Drug classNoradrenergic and specific serotonergic antidepressant (NaSSA)
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability50%
Protein binding85%
MetabolismLiver (CYP1A2, CYP2D6, CYP3A4)
MetabolitesDesmethylmirtazapine (contributes 3–10% of activity)
Elimination half-life20–40 hours
ExcretionUrine: 75%
Feces: 15%
Identifiers
  • (±)-5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC17H19N3
Molar mass265.36 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
Density1.22 g/cm3
Melting point114 to 116 °C (237 to 241 °F)
Boiling point432 °C (810 °F)
Solubility in waterSoluble in methanol and chloroform mg/mL (20 °C)
  • n1cccc3c1N4C(c2ccccc2C3)CN(C)CC4
  • InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3 checkY
  • Key:RONZAEMNMFQXRA-UHFFFAOYSA-N checkY
  (verify)


Főnév

mirtazapine (tsz. mirtazapines)

  1. (gyógyszertan) mirtazapin